ConductScience.org, home

Paper6428895

The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.

Langdon SP and 3 others. Eur J Cancer Clin Oncol, 1984. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma. Papers, record 6428895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6428895

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The chemosensitivity of a new experimental model--the M5076 reticulum cell sarcoma.
PubMed
Journal
Eur J Cancer Clin Oncol
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2019-09-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Langdon SPS P
2Gescher AA
3Hickman JAJ A
4Stevens MFM F

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Lymphoma, Non-HodgkinMajor topic
Altretamine
Animals
Cell Line
Drug Administration Schedule
Female
Formamides
Mice
Neoplasm Transplantation
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
8449965Effect of cisplatin on primary tumour growth and liver metastases in the M 5076 reticulum sarcoma: implication for new screening modalities.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8449965PubMed
8188734Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.J Cancer Res Clin Oncol1994https://conductscience.org/library/papers/8188734PubMed
7656502Clinical pharmacokinetics of altretamine.Clin Pharmacokinet1995https://conductscience.org/library/papers/7656502PubMed
7641606Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.Drugs1995https://conductscience.org/library/papers/7641606PubMed
3948299The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948299PubMed
3665221Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.Clin Exp Metastasis1987https://conductscience.org/library/papers/3665221PubMed
2598180Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2598180PubMed
1783523Antitumor activity and mechanism of action of the marine compound girodazole.Invest New Drugs1991https://conductscience.org/library/papers/1783523PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6428895

GET https://conductscience.org/api/papers/v1/6428895/authors